Official Title: US-based Observational Drug Registry of Opsumit Macitentan New Users in Clinical Practice
Status: COMPLETED
Status Verified Date: 2020-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OPUS
Brief Summary: Prospective observational drug registry developed to characterize the safety profile including primarily potential serious hepatic risks and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting